Company: IMNN
Filing Date: 2025-05-30
Form Type: PRE 14A
Source: 0001641172-25-013068
Chunk: 55

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: PRE 14A
Chunk 55
---
 of the Reverse Stock Split on the number of shares of our common stock that would be issued and outstanding, authorized and reserved for issuance and authorized and unreserved for issuance based on our capitalization as of May 28, 2025:

|                                        |     | Shares                 
 Issued and Outstanding |            |     | Shares                               
 Authorized and Reserved for Issuance |            |     | Shares                                 
 Authorized and Unreserved for Issuance |             |     | Total      
 Authorized |             |
| As of May 28, 2025                     |     |                        | 20,319,511 |     |                                      | 23,689,656 |     |                                        |  68,490,833 |     |            | 112,500,000 |
| Following 5-for-1 Reverse Stock Split  |     |                        |  4,063,902 |     |                                      |  4,737,931 |     |                                        | 103,698,167 |     |            | 112,500,000 |
| Following 10-for-1 Reverse Stock Split |     |                        |  2,031,951 |     |                                      |  2,368,966 |     |                                        | 108,099,083 |     |            | 112,500,000 |
| Following 18-for-1 Reverse Stock Split |     |                        |  1,128,862 |     |                                      |  1,316,092 |     |                                        | 110,055,046 |     |            | 112,500,000 |

The table above does not take into account the treatment of fractional shares.

Reasons for the Reverse Stock Split

The Board believes that the increase in the number of available shares of common stock following the Reverse Stock Split will provide the Company with the ability to support its future anticipated growth and would provide greater flexibility to consider and respond to future business opportunities and needs as they arise, including equity financings and stock-based acquisitions of new technology and product development candidates. The availability of additional shares of common stock would permit the Company to undertake certain of the foregoing actions without delay and expense associated with holding an Annual or Special Meeting of Stockholders to obtain stockholder approval each time such an opportunity arises that would require the issuance of shares of our common stock.

Further, the Company compensates key employees through equity-based compensation programs. This compensation program is essential to the high-risk nature of the business and provides the ability to align the interests of